STAT's Alex Hogan covered JPM 2026 on STATus Report, focusing on mood, big talk and artificial intelligence (AI) billboards.[3] The JPMorgan Healthcare Conference 2026 highlights AI, data and digital transformation as key themes.[3] Ethics, prevention of bias and protection of patient data are discussed as key barriers to adoption.[3][4] The real use of AI is moving from theoretical enthusiasm to measurable value in practice.[3] Zifo says at the conference that technology alone is not enough to fulfill the promises of AI in drug discovery, but a holistic PDOT approach (processes and data, organization, technology) is needed.[4] Firms such as banks (BBVA, JPMorgan Chase) are building "AI factories" as a combination of platforms, methods and data for sustainable competitive advantage.[1] JPMorgan predicts AI-driven investment growth that could push the S&P 500 above 8,000 points.[2]